[ARWR] YoY Quarter Result on 30-Jun-2019 [#Q3]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q3]
Profit Trend
QoQ- -14.90%
YoY- 230.31%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 32,412 45,891 27,376 42,697 727 9,342 40 205.17%
PBT -72,046 -29,924 -13,611 20,336 -15,606 -5,520 -19,421 24.40%
Tax -863 -1,280 0 0 0 -194 79 -
NP -71,183 -29,924 -13,611 20,336 -15,606 -5,520 -19,421 24.15%
Tax Rate - - - 0.00% - - - -
Total Cost 103,595 75,815 40,987 22,361 16,333 14,862 19,460 32.12%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -219.62 -65.21 -49.72 47.63 -2,145.53 -59.08 -49,063.34 -59.38%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.67 -0.29 -0.13 0.21 -0.18 -0.07 -0.32 13.10%
EPS Diluted -0.67 -0.29 -0.13 0.21 -0.18 -0.07 -0.32 13.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.